BL Pharmtech

(주)비엘팜텍 · KOSDAQ · 065170 · Industry: Wholesale of food, beverages and tobaccos

Key metrics

Earnings

Revenue, Q3 2026₩1.1bn As of Sep 30, 2026 Source 1 ↗
Revenue QoQ+56.8% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Revenue YoY+23.4% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income, Q3 2026₩32m As of Sep 30, 2026 Source 1 ↗
Operating income QoQTurned to profit As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income YoYTurned to profit As of Sep 30, 2026 Source 1 ↗, Source 2 ↗

Share buybacks

Buyback decided, last 3 months₩0 As of Nov 19, 2026
Buyback decided, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 3 months₩0 As of Nov 19, 2026
Shares acquired, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 3 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 3 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Buyback decided, last 12 months₩0 As of Nov 19, 2026
Buyback decided, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 12 months₩0 As of Nov 19, 2026
Shares acquired, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 12 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 12 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗

Potential dilution

CB/BW/EB issued, last 12 months₩0 As of Nov 19, 2026
Rights offering new shares, last 12 months0 shares As of Nov 19, 2026
Potential new shares, last 12 months0 shares As of Nov 19, 2026
Potential new shares, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Conversion price adjustments, last 12 months0 As of Nov 19, 2026

Supply contracts

Supply contracts, last 12 months₩0 As of Nov 19, 2026
Supply contracts vs prior-year revenue0.0% As of Nov 19, 2026
Contracts without a KRW amount0 contracts without a KRW amount excluded As of Nov 19, 2026

Disclosure activity

DART filings, last 3 months2 As of Nov 19, 2026
DART filings, previous 3 months3 As of Nov 19, 2026

Insider transactions

Open-market buys, last 12 months (shares)159,774 shares As of Jan 20, 2026 Source 1 ↗, Source 2 ↗
Open-market buys, last 12 months (amount)₩76m As of Jan 20, 2026 Source 1 ↗, Source 2 ↗
Open-market sells, last 12 months (shares)0 shares As of Nov 19, 2026
Open-market sells, last 12 months (amount)₩0 As of Nov 19, 2026
Net open-market buying, last 12 months (shares)159,774 shares As of Jan 20, 2026 Source 1 ↗, Source 2 ↗
Insiders who bought, last 12 months1 As of Jan 20, 2026 Source 1 ↗, Source 2 ↗

Insider transactions (last 12 months)

Open-market buys: 159,774 shares (₩76m). Open-market sells: 0 shares (₩0). Net open-market buying: +159,774 shares. Insiders who bought: 1.

Trade dateInsider (role)TypeSharesPriceAmount
Jan 20, 2026Park Yeong-cheol (Registered director, 10%+ shareholder)Open-market buy+14,000 shares₩578₩8m
Jan 15, 2026Park Yeong-cheol (Registered director, 10%+ shareholder)Open-market buy+15,000 shares₩529₩8m
Jan 14, 2026Park Yeong-cheol (Registered director, 10%+ shareholder)Open-market buy+50,000 shares₩515₩26m
Jan 13, 2026Park Yeong-cheol (Registered director, 10%+ shareholder)Open-market buy+20,700 shares₩453₩9m
Jan 12, 2026Park Yeong-cheol (Registered director, 10%+ shareholder)Open-market buy+60,074 shares₩420₩25m

Annual financials

YearRevenueOperating income
2025₩6.5bn-₩2.8bn
2024₩8.8bn-₩3.2bn
2023₩24.5bn-₩6.8bn

Filing timeline